Ultrasound features and preoperative accuracy of the fine needle aspiration biopsy in detection of thyroid carcinomas.


Journal

Journal of clinical ultrasound : JCU
ISSN: 1097-0096
Titre abrégé: J Clin Ultrasound
Pays: United States
ID NLM: 0401663

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 22 05 2022
received: 19 12 2021
accepted: 25 05 2022
pubmed: 22 9 2022
medline: 15 11 2022
entrez: 21 9 2022
Statut: ppublish

Résumé

To analyze the ultrasound (US) characteristics and fine needle biopsy (FNAB) of thyroid carcinomas (TCs) prior to surgery and compare with postoperative histopathology and to determine FNAB sensitivity and specificity. Retrospective analysis of the US data during 1999-2015 was performed, as well as analysis of FNAB results and using histopathology report as "gold standard" the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of this method was evaluated. Data revealed that tumors >51 mm were declining by 50% in the period 2011-2015 compared to 2005-2010 or by 18% 2011-2015 compared to 1999-2004 and significant increase was detected in diagnosis of multicentric tumors. The analysis revealed that FNAB has sensitivity = 65.7% CI (0.59% - 0.71%) and specificity = 50% CI (0.43%-0.56%), PPV = 56.9% and NPV = 59.2%. We found increasing detection of smaller TCs, as well as more frequent detection of multicentricity of the neoplastic foci. FNAB results in our study revealed low sensitivity and specificity. Major limitation of the study was inability to exactly separate US guided from non US guided FNAB in evaluation of the sensitivity and specificity, due to retrospective nature of the analysis. Further studies evaluating only US guided FNAB should be performed.

Identifiants

pubmed: 36129366
doi: 10.1002/jcu.23302
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1338-1344

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Katoh H, Yamashita K, Enomoto T, Masahiko W. Classification and general considerations of thyroid cancer. Ann Clin Pathol. 2015;3(1):1045-1054.
Schumberger M, Pacini F, Tutle RM. Thyroid Tumors. 4th ed. Institute Medico-Educatif; 2015.
Alexander EK, Bible KC, Doherty GM, et al. American Thyroid Association Management Guidelines for adult patientswith thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;26((1)):1-133. doi:10.1089/thy.2015.0020
De Groot LJ, Reed Larsen P, Hennemann G. The Thyroid and its Diseases. 6th ed. Churchill Livingstone; 1995.
Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94:1748-1751.
Na DG, Baek JH, Sung JY, et al. Thyroid imaging reporting and data system risk stratification of thyroid nodules: categorization based on solidity and echogenicity. Thyroid. 2016;26:562-572.
Gharib H, Dean D. Chapter 6d. Fine-Needle Aspiration Biopsy of the Thyroid Gland. https://www.ncbi.nlm.nih.gov/books/NBK285544/
La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136:2187-2195. doi:10.1002/ijc.29251/epdf
Moriss LG, Sikora AG, Tosteson TD, Davis L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23(7):885-891. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704124/pdf/thy.2013.0045.pdf
Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol. 2004;11(12):1093-1097. http://www.ncbi.nlm.nih.gov/pubmed/15576834
Muratli A, Erdogan N, Sevim S, Unal I, Akyuz S. Diagnostic efficacy and importance of fine-needle aspiration cytology of thyroid nodules. J Cytol. 2014;31(2):73-78. doi:10.4103/0970-9371.138666
Poller DN, Stelow EB, Yiangou C. Thyroid FNAC cytology: can we do it better? Cytopathology. 2008;19(1):4-10.
Scopa CD. Histopathology of thyroid tumors. An overview. Hormones. 2004;3(2):100-110. http://www.hormones.gr/pdf/1116414588.pdf
Majstorov V. Ultrasonographic findings in patients with benign and malignant thyroid nodules who underwent ultrasound guided fine needle aspiration cytology. OAMJMS. 2015;3(4):689-693.
Zhong LC, Feng L, Fang M, et al. Ultrasound-guided fine-needle aspiration of thyroid nodules: does the size limit its efficiency? Int J Clin Exp Pathol. 2015;8(3):3155-3159.
Corapcioglu D, Sak SD, Delibasi T, et al. Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of the p53 protein in papillary microcarcinomas. J Transl Med. 2006;4(28):1-6.
Chow LS, Gharib H, Goellner JR, Van Heerden JA. Non diagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid. 2001;11(12):1147-1151. https://www.ncbi.nlm.nih.gov/pubmed/12186502
Paschke R, Cantara S, Crescenzi A. ETA guidelines regarding thyroid nodule molecular fine - needle aspiration cytology diagnostics. Eur Thyroid J. 2017;6:115-129.
Layfield LJ, Abrams J, Cochand-Priollet B, et al. Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute thyroid fine needle aspiration state ofthe science conference. Diagn Cytopathol. 2008;36:442-448.
Cantara S, Capezzone M, Marchisotta S, et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab. 2010;95:1365-1369.
Ho AS, Sarti EE, Jain KS, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AYS/FLUS). Thyroid. 2014;24(5):832-839. doi:10.1089/thy.2013.0317
Gweon HM, Son EJ, Youk JH, Kim JA. Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step? Ann Surg Oncol. 2013;20:3083-3088. doi:10.1245/s10434-013-2990-x
Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86(4):1447-1463.
Lee EK, Chung KW, Min HS, et al. Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci. 2012;27:1014-1018.

Auteurs

Tanja Makazlieva (T)

Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.

Bojana Stoilovska Rizova (B)

Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.

Sinisa Stojanoski (S)

Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.
Medical Faculty, Lazarski University, Warsaw, Poland.

Nevena Manevska (N)

Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.

Olivija Vaskova (O)

Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.

Vesna Velikj Stefanovska (V)

Institute of Epidemiology and Biostatistics with Medical Informatics, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.

Daniela Miladinova (D)

Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, University Ss Cyril and Methodius, Skopje, Republic of North Macedonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH